Cargando…
Radioimmunotherapy with an (211)At‐labeled anti–tissue factor antibody protected by sodium ascorbate
Tissue factor (TF), the trigger protein of the extrinsic blood coagulation cascade, is abundantly expressed in various cancers including gastric cancer. Anti‐TF monoclonal antibodies (mAbs) capable of targeting cancers have been successfully applied to armed antibodies such as antibody‐drug conjugat...
Autores principales: | Takashima, Hiroki, Koga, Yoshikatsu, Manabe, Shino, Ohnuki, Kazunobu, Tsumura, Ryo, Anzai, Takahiro, Iwata, Nozomi, Wang, Yang, Yokokita, Takuya, Komori, Yukiko, Mori, Daiki, Usuda, Sachiko, Haba, Hiromitsu, Fujii, Hirofumi, Matsumura, Yasuhiro, Yasunaga, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088967/ https://www.ncbi.nlm.nih.gov/pubmed/33606344 http://dx.doi.org/10.1111/cas.14857 |
Ejemplares similares
-
Stabilization of an (211)At-Labeled Antibody
with Sodium Ascorbate
por: Manabe, Shino, et al.
Publicado: (2021) -
Tumor
Targeting of (211)At-Labeled Antibody
under Sodium Ascorbate Protection against Radiolysis
por: Takashima, Hiroki, et al.
Publicado: (2022) -
Protection from contamination by (211)At, an enigmatic but promising alpha-particle-emitting radionuclide
por: Ohnuki, Kazunobu, et al.
Publicado: (2022) -
Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
por: Tsumura, Ryo, et al.
Publicado: (2019) -
ET-05 PRECLINICAL STUDY OF AN ANTI-HUMAN TISSUE FACTOR ANTIBODY-DRUG CONJUGATE IN A MALIGNANT GLIOMA XENOGRAFT MODEL
por: Takashima, Hiroki, et al.
Publicado: (2019)